[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340652-105":59,"doc-detail-340652-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-model-based-on-disulfidptosis-related-lncrnas-for-predicting-survival-and-therapeutic-response-in-bladder-cancer","Prognostic model based on disulfi dptosis-related lncRNAs for predicting survival and therapeutic response in bladder cancer","","Bladder cancer continues to drive clinical research in precision oncology due to poor outcomes and highly variable prognosis. This study investigates whether disulfidptosis-related long non-coding RNAs can support selective cancer cell killing and improve survival prediction. Key disulfidptosis-associated lncRNAs were identified, integrated into a prognostic risk model, and validated using quantitative PCR. The model separates patients by risk, links high-risk biology to PI3K-Akt signaling, extracellular matrix organization, and immune escape, and suggests greater sensitivity to Sorafenib, Oxaliplatin, and MK-2206 as potential therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-model-based-on-disulfidptosis-related-lncrnas-for-predicting-survival-and-therapeutic-response-in-bladder-cancer/340652/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-model-based-on-disulfidptosis-related-lncrnas-for-predicting-survival-and-therapeutic-response-in-bladder-cancer/340652.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study aim to predict for bladder cancer patients?","Question",{"text":112,"@type":113},"It aims to predict patient survival and therapeutic response using disulfidptosis-related long non-coding RNAs.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were disulfidptosis-related lncRNAs used in the study?",{"text":117,"@type":113},"Key lncRNAs were identified, then integrated into a prognostic risk model that was validated for reliability and validity.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biological pathways and treatment sensitivities are associated with high-risk patients?",{"text":121,"@type":113},"High-risk patients showed higher expression of genes in the PI3K-Akt pathway, extracellular matrix organization, and immune escape mechanisms, and they demonstrated higher sensitivity to Sorafenib, Oxaliplatin, and MK-2206.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340652,1790541901,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Original Research PUBLISHED 02 December 2024 DOI 10.3389/fimmu.2024.1512203  \nOPEN ACCESS  \nEDITED BY  \nVinay Kumar,  \nThe Pennsylvania State University, United States  \nREVIEWED BY  \nJagadeesh Uppala,  \nMedical College of Wisconsin, United States Satish Raut,  \nThe Ohio State University, United States  \n*CORRESPONDENCE  \nYubo Liu  \n [liuyubo@dlut.edu.cn](liuyubo@dlut.edu.cn)[ ](liuyubo@dlut.edu.cn)Wei Wang  \n[w14901@yahoo.com](w14901@yahoo.com)  \n†These authors have contributed equally to this work  \nRECEIVED 16 October 2024  \nACCEPTED 12 November 2024  \nPUBLISHED 02 December 2024  \nCITATION  \nHan L, Yang H, Jiang X, Zhou Z, Ge C, Yu K, Li G, Wang W and Liu Y (2024) Prognostic model based on disulﬁdptosis-related lncRNAs for predicting survival and therapeutic response in bladder cancer. Front. Immunol. 15:1512203 .  \ndoi: 10.3389/fimmu.2024.1512203  \nCOPYRIGHT  \n© 2024 Han, Yang, Jiang, Zhou, Ge, Yu, Li, Wang and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPrognostic model based on disulﬁdptosis-related lncRNAs for predicting survival and therapeutic response in bladder cancer  \nLirui Han 1†, Hankai Yang 1†, Xuan Jiang 1, Ziyu Zhou 1, Chang Ge 1, Kairan Yu 1, Guofang Li 1, Wei Wang 2,3* and Yubo Liu 1,2*  \n1 Department of Life and Pharmaceutical Sciences, School of Chemical Engineering, Ocean and Life Sciences, Dalian University of Technology, Panjin, China, 2 Ministry of Education (MOE) Key Laboratory of Bio-Intelligent Manufacturing, Dalian University of Technology, Dalian, China, 3 Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, Liaoning, Shenyang, China  \nBackground: With poor treatment outcomes and prognosis, bladder cancer remains a focus for clinical research in the precision oncology era. However, the potential of disulﬁdptosis, a novel cell death mechanism, and its related long non-coding RNAs to support selective cancer cell killing in this disease is still unclear.  \nMethods: We identiﬁed key disulﬁdptosis-related lncRNAs in bladder cancer, constructed a prognostic risk model with potential therapeutic targets, and conﬁrmed the ﬁndings through quantitative PCR analysis.  \nResults: We identiﬁed ﬁve crucial lncRNAs (AC005840 .4 , AC010331 .1, AL021707.6 , MIR4435-2HG and ARHGAP5-AS1) and integrated them into a predictive model centered on disulﬁdptosis-associated lncRNAs. Reliability and validity tests demonstrated that the lncRNA prediction index associated with disulﬁdptosis effectively discerns patients ’ prognosis outcomes. Additionally, high-risk patients exhibited elevated expression levels of genes involved in the PI3K-Akt signaling pathway, extracellular matrix organization, and immune escape mechanisms, which are associated with poor prognosis. Notably, highrisk patients demonstrated higher sensitivity to Sorafenib, Oxaliplatin and MK- 2206, underscoring the promise of these lncRNAs as precise therapeutic targets in bladder cancer.  \nConclusion: By revealing the predictive importance of disulﬁdptosis-associated lncRNAs in bladder cancer, our research offers new perspectives and pinpoints potential therapeutic targets in clinical environments.  \nKEYWORDS  \ndisulﬁdptosis, bladder cancer, long non-coding RNA, machine learning, prognosis  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nBladder cancer (BC) is one of the most common malignant tumors affecting the urinary system, posing substantial challenges to global healthcare (1, 2) . The incidence of BC varies widely, encompassing both occult,","cbCaibsam8ltvaFP","https://ap.wps.com/l/cbCaibsam8ltvaFP","pdf",11415014,15,"English","# Introduction\n## Methods and study approach\n## Results\n## Conclusion","[{\"question\":\"What does the study aim to predict for bladder cancer patients?\",\"answer\":\"It aims to predict patient survival and therapeutic response using disulfidptosis-related long non-coding RNAs.\"},{\"question\":\"How were disulfidptosis-related lncRNAs used in the study?\",\"answer\":\"Key lncRNAs were identified, then integrated into a prognostic risk model that was validated for reliability and validity.\"},{\"question\":\"Which biological pathways and treatment sensitivities are associated with high-risk patients?\",\"answer\":\"High-risk patients showed higher expression of genes in the PI3K-Akt pathway, extracellular matrix organization, and immune escape mechanisms, and they demonstrated higher sensitivity to Sorafenib, Oxaliplatin, and MK-2206.\"}]","Prognostic model based on disulfi dptosis-related lncRNAs for predicting survival and therapeutic response in bladder cancer | PDF",1790037917,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0aa7ae430743777b8c3b813fa2c910a.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/599a18bd0ac0b99d32bb83dd962f82e9.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9dfada0a9a4cd47c96ac8c8838136e7.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4602621a0cfb78d7d2a9faf65e3dcd8.webp",980,1385]